Inside the chest, the thymus gland functions like a school for immune cells. Rare “teacher” cells called thymic epithelial cells (TECs) instruct T cells to go after foreign invaders while leaving healthy tissue alone. TECs account for less than one percent of the gland’s cells, and for decades labs have struggled to agree on how to study them.

In a study published in the Journal of Immunology, Cold Spring Harbor Lab Assistant Professor Hannah Meyer and her team describe a dependable approach for extracting, identifying, and classifying these cells. Applying it, they also pinpointed a distinct population of TECs.

The thymus bears on longevity and on the body’s ability to fight cancer, which makes the lack of standard methods a real obstacle. Without them, Meyer says, researchers “can’t actually make big strides in gaining new insights into such an important aspect of human health.”

Part of the difficulty is physical. TECs cling to the tissue around them, and no universal technique exists for freeing them. Each lab tends to use its own mix of enzymes in its own proportions to break down the organ before sorting the cells. “Even if we use the same reagents, we just can’t reproduce the result,” Meyer says.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

To build a common method, the team worked with 15 human thymus samples. They determined how much tissue is needed for accurate analysis, compared different enzyme recipes, and worked out which labels best tell the cell types apart. The outcome is a panel of seven markers that any lab can adopt with ease.

Meyer says the aim was to “recommend a minimal standard that could make the research much more reproducible.” The team urges immunology labs, including clinical ones, to use the published protocols so the research community can work together more effectively.

The stakes extend beyond the lab bench. Because the thymus trains the full range of immune cells, problems with it underlie many conditions, including type 1 diabetes and arthritis, and the absence of standard methods has long slowed needed research. “If we understand the molecular basis of the thymus gland, we can understand its regeneration better and help improve health outcomes,” Meyer says.